Abstract:Background: Obtaining membrane proteins in sufficient quantity for biophysical study and biotechnological applications has been a difficult task. Use of the maltose binding protein/hexahistidine dual tag system with E.coli as an expression host is emerging as a high throughput method to enhance membrane protein yield, solubility, and purity, but fails to be effective for certain proteins. Optimizing the variables in this system to fine-tune for efficiency can ultimately be a daunting task. To identify factors critical to success in this expression system, we have selected to study U24, a novel membrane protein from Human Herpesvirus type-6 with potent immunosuppressive ability and a possible role in the pathogenesis of the disease multiple sclerosis. Results: We expressed full-length U24 as a C-terminal fusion to a maltose binding protein/hexahistidine tag and examined the effects of temperature, growth medium type, cell strain type, oxidizing vs. reducing conditions and periplasmic vs. cytoplasmic expression location. Temperature appeared to have the greatest effect on yield; at 37°C full-length protein was either poorly expressed (periplasm) or degraded (cytoplasm) whereas at 18°C, expression was improved especially in the periplasm of C41(DE3) cells and in the cytoplasm of oxidizing Δtrx/Δgor mutant strains, Origami 2 and SHuffle. Expression of the fusion protein in these strains were estimated to be 3.2, 5.3 and 4.3 times greater, respectively, compared to commonly-used BL21(DE3) cells. We found that U24 is isolated with an intramolecular disulfide bond under these conditions, and we probed whether this disulfide bond was critical to high yield expression of full-length protein. Expression analysis of a C21SC37S cysteine-free mutant U24 demonstrated that this disulfide was not critical for full-length protein expression, but it is more likely that strained metabolic conditions favour factors which promote protein expression. This hypothesis is supported by the fact that use of minimal media could enhance protein production compared to nutrient-rich LB media. Conclusions: We have found optimal conditions for heterologous expression of U24 from Human Herpesvirus type-6 in E.coli and have demonstrated that milligram quantities of pure protein can be obtained. Strained metabolic conditions such as low temperature, minimal media and an oxidizing environment appeared essential for high-level, full-length protein production and this information may be useful for expressing other membrane proteins of interest.

Recombinant expression, purification, and characterization of full-length human BST-2 from Escherichia coli

Identification of Novel Key Amino Acids at the Interface of the Transmembrane Domains of Human BST-2 and HIV-1 Vpu.

Constructing Prokaryotic Vector of BC047440 Gene Expression and Purification of Its Recombinant Protein

Expression Of Bst-2 Fusion Protein In Eukaryotic Cells

High-Throughput NanoBiT-Based Screening for Inhibitors of HIV-1 Vpu and Host BST-2 Protein Interaction

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Role of the Endocytic Pathway in the Counteraction of BST-2 by Human Lentiviral Pathogens

Overexpression and purification of U24 from human herpesvirus type-6 in E. coli: unconventional use of oxidizing environments with a maltose binding protein-hexahistine dual tag to enhance membrane protein yield

Expression, Purification, and Renaturation of a Recombinant Peptide-Based HIV Vaccine in Escherichia Coli.

Expression and purification of the complete PreS region of hepatitis B Virus

Cloning, Expression, Purification and Activity of the Hsblys.

Expression, purification, and characterization of recombinant human soluble BAFF secreted from the yeast Pichia pastoris

Two‐Step Preparation of Highly Pure, Soluble HIV Protease from Inclusion Bodies Recombinantly Expressed in Escherichia coli

Prokaryotic Expression and Purification of HIV-1 Vif and Hapobec3g, Preparation of Polyclonal Antibodies

A heterocyclic compound inhibits viral release by inducing cell surface BST2/Tetherin/CD317/HM1.24

Recombinant Expression, Purification and Characterization of Human Soluble Tumor Necrosis Factor Receptor 2.

Integrate Thermostabilized Fusion Protein Apocytochrome B 562 RIL and N-glycosylation Mutations: A Novel Approach to Heterologous Expression of Human UDP-glucuronosyltransferase (UGT) 2B7.

[Clonging, Expression and Activity Determination of the Recombinant Human Soluble B Lymphocyte Stimulator and Its Two Mutants].

Expression and Purification of Secreted Recombinant Hsp60 from Eukaryotic Cells